High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
NCT06337552 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2026-05-26
Summary
The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.
Conditions
Interventions
- OTHER
-
FEED-FF
3-6 servings of any combination of the following fermented foods/day (from 1 week prior to treatment to approximately 12 weeks after the start of treatment): Yogurt, cottage cheese, kefir, kombucha, sauerkraut, and kimchi.
- OTHER
-
Standard of Care (SUC)
Standard of Care (SUC) is the treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by health care professionals. Standard of Care will comprise general healthy eating handouts that describe typical healthy foods and the suggested level of servings per day.
Sponsors & Collaborators
-
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Principal Investigators
-
Doratha (Armen) Byrd, PhD, MPH · Moffitt Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-04
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer
NCT02176746 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dietary Fiber and Probiotics in Advanced Colorectal Cancer
NCT07194954 ·Status: COMPLETED ·Phase: NA
-
Oral & Faecal Microbiota Analysis in Patients With Rectal Cancer Requiring Pre-operative Therapy Before Surgery, & Correlation With Response
NCT04601727 ·Status: COMPLETED
-
The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease
NCT06938165 ·Status: COMPLETED ·Phase: NA
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364 ·Status: RECRUITING ·Phase: PHASE1
-
Mix Vaccine for Metastatic Colorectal Cancer
NCT03357276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Microbiome and Rectal Cancer
NCT04223102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1
NCT04130763 ·Status: COMPLETED ·Phase: PHASE1
-
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
NCT06998758 ·Status: RECRUITING ·Phase: PHASE3
-
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
NCT03532711 ·Status: COMPLETED
-
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT05023720 ·Status: UNKNOWN
-
Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients
NCT00502502 ·Status: COMPLETED
-
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
NCT05273255 ·Status: COMPLETED ·Phase: NA
-
Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
NCT06181201 ·Status: TERMINATED
-
The Microbrect-FFC Study
NCT06236321 ·Status: UNKNOWN ·Phase: NA
-
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149 ·Status: UNKNOWN
-
Gut Microbiota Reconstruction for NSCLC Immunotherapy
NCT05008861 ·Status: UNKNOWN ·Phase: PHASE1
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA
-
Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology
NCT05664178 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
NCT00960427 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients
NCT06659237 ·Status: COMPLETED